May 10, 2022
AccurKardia
AccurKardia is an ECG-led diagnostics software company transforming ECGs into a more powerful diagnostic tool and broad biomarker. Our platform AccurECG™, an FDA-cleared Class II SaMD delivering fully automated, near real time ECG interpretation that integrates into clinical workflows. AccurECG™ was named “Best New ECG Technology” (MedTech Breakthrough 2025).
Start the conversation: [email protected]
Clinical pilots / feasibility studies 
Validation or real-world evidence 
Research collaboration 
Advisory input from clinicians or scientists
